Assembly Biosciences, Inc. (ASMB)
34.07
-0.73
(-2.10%)
USD |
NASDAQ |
Aug 28, 16:00
34.00
-0.07
(-0.21%)
After-Hours: 20:00
Assembly Biosciences Shareholders Equity (Quarterly) : 305.65M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 305.65M |
| March 31, 2026 | 198.61M |
| December 31, 2025 | 206.75M |
| September 30, 2025 | 182.70M |
| June 30, 2025 | 18.10M |
| March 31, 2025 | 27.13M |
| December 31, 2024 | 33.36M |
| September 30, 2024 | 26.00M |
| June 30, 2024 | 34.68M |
| March 31, 2024 | 32.60M |
| December 31, 2023 | 41.10M |
| September 30, 2023 | 41.71M |
| June 30, 2023 | 54.95M |
| March 31, 2023 | 70.33M |
| December 31, 2022 | 82.66M |
| September 30, 2022 | 102.40M |
| June 30, 2022 | 123.98M |
| March 31, 2022 | 146.79M |
| December 31, 2021 | 168.93M |
| September 30, 2021 | 224.64M |
| June 30, 2021 | 231.79M |
| March 31, 2021 | 247.24M |
| December 31, 2020 | 240.58M |
| September 30, 2020 | 270.55M |
| June 30, 2020 | 267.12M |
| Date | Value |
|---|---|
| March 31, 2020 | 251.77M |
| December 31, 2019 | 273.22M |
| September 30, 2019 | 156.49M |
| June 30, 2019 | 174.71M |
| March 31, 2019 | 190.40M |
| December 31, 2018 | 210.65M |
| September 30, 2018 | 229.43M |
| June 30, 2018 | 89.10M |
| March 31, 2018 | 102.38M |
| December 31, 2017 | 113.12M |
| September 30, 2017 | 47.13M |
| June 30, 2017 | 56.54M |
| March 31, 2017 | 67.89M |
| December 31, 2016 | 79.88M |
| September 30, 2016 | 90.04M |
| June 30, 2016 | 100.56M |
| March 31, 2016 | 109.28M |
| December 31, 2015 | 118.74M |
| September 30, 2015 | 125.40M |
| June 30, 2015 | 130.87M |
| March 31, 2015 | 124.62M |
| December 31, 2014 | 58.57M |
| September 30, 2014 | 47.20M |
| June 30, 2014 | 20.29M |
| March 31, 2014 | 22.44M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 11.83B |
| BridgeBio Pharma, Inc. | -2.515B |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 330.83M |
| Total Liabilities (Quarterly) | 25.18M |
| Debt to Equity Ratio | 0.0077 |
| Current Ratio | 13.99 |
| Net Debt Paydown Yield | 0.02% |